Diuretic use in patients with cirrhosis and complications of portal hypertension: Should we rethink the use of furosemide as first line?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diuretic use in patients with cirrhosis and complications of portal hypertension: Should we rethink the use of furosemide as first line?

Published:2024-01 Issue:1 Volume:23 Page:
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:

Author:

Huang Linda¹^ORCID,Han Hyosun²^ORCID

Affiliation:

1. Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA

2. Department of Medicine, Division of Gastrointestinal & Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference19 articles.

1. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies;D’Amico;J Hepatol,2006

2. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis;Bernardi;J Hepatol,2015

3. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis;Schrier;Hepatology,1988

4. Clinical pharmacology of loop diuretics;Brater;Drugs,1991

5. A comprehensive review of the loop diuretics: Should furosemide be first line?;Wargo;Ann Pharmacother,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP